COMMUNIQUÉS West-GlobeNewswire

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
03/09/2019
BOSTON, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]
BioTelemetry, Inc. Named to Fortune Magazine’s 100 Fastest-Growing Companies List
03/09/2019
MALVERN, Pa., Sept. 03, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost [...]
Novan Hires Michelle Patterson as Vice President of Project Management
03/09/2019
Underscores Company’s preparation for potential NDA submission for SB206 in molluscum Role to lead cross-functional coordination of key activities and timelines for the program SB206 top line results are expected no [...]
Crinetics Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference
03/09/2019
SAN DIEGO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
Stereotaxis Announces Uplisting to NYSE American
03/09/2019
ST. LOUIS, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that its common stock has been [...]
Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and Director
03/09/2019
MORRISTOWN, N.J., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (Nasdaq: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial [...]
HealthEquity Reports Second Quarter Ended July 31, 2019 Financial Results
03/09/2019
Highlights of the second quarter include: Revenue of $86.6 million, an increase of 22% compared to Q2 FY19. Net income of $19.4 million, a decrease of 14% compared to $22.5 million in Q2 FY19. Net income per diluted [...]
Eton Pharmaceuticals to Participate in Lake Street 3rd Annual Best Ideas Growth Conference
03/09/2019
DEER PARK, Ill., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that [...]
Bio-Path Holdings to Present at the H.C. Wainwright 21st Annual Global Investment Conference
03/09/2019
HOUSTON, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]
Turning Point Therapeutics Announces Updated Interim Clinical Data of Repotrectinib and Preclinical Data for TPX-0046, a Novel RET/SRC Inhibitor
03/09/2019
In TKI-naïve ROS1+ NSCLC Patients, Overall Response Rate by Blinded Review Improved to 91 Percent; Median Duration of Response Not Yet Mature with 20.1 months of Median Follow-Up Improved Results in Heavily Pretreated [...]
Forty Seven Inc. to Present at Morgan Stanley 17th Annual Global Healthcare Conference
03/09/2019
MENLO PARK, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]
LHC Group to Present at Baird 2019 Healthcare Conference
03/09/2019
LAFAYETTE, La., Sept. 03, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting at the Baird 2019 Healthcare Conference in New York on Thursday, September 5, 2019 at 1:25 [...]
Fulcrum Therapeutics to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
03/09/2019
CAMBRIDGE, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare [...]
Collegium to Participate in Upcoming Investor Conferences
03/09/2019
STOUGHTON, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that [...]
Cytokinetics to Present at September Investor Conferences
03/09/2019
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate [...]
Taconic Biosciences participe à la deuxième mission de référence en matière de recherche sur les rongeurs à bord de la Station spatiale internationale
03/09/2019
Les études qui en résulteront fourniront des données de référence essentielles pour stimuler les progrès en santé humaine RENSSELAER, New York, 03 sept. 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, un chef de file [...]
OSE Immunotherapeutics Receives New European Patent Protection Through 2037 for OSE-703, a Cytotoxic Monoclonal Antibody Targeting IL-7R, in Cancer Patients
03/09/2019
NANTES, France, Sept. 03, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Euronext: OSE) today announces the grant of a new patent from the European Patent Office (EPO) strengthening the protection [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 31 Août 2019
03/09/2019
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers LYON, France, 03 sept. 2019 (GLOBE NEWSWIRE) -- Places de cotation : Euronext Paris de Euronext (Compartiment C - Code ISIN : FR0011471135 – [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 31 Août 2019
03/09/2019
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers LYON, France, 03 sept. 2019 (GLOBE NEWSWIRE) -- Places de cotation : Euronext Paris de Euronext (Compartiment C - Code ISIN : FR0011471135 – [...]

Pages